Cystic Fibrosis Foundation - Dec 8, 2022 Form 3 Insider Report for Aridis Pharmaceuticals, Inc. (ARDS)

Role
10%+ Owner
Signature
/s/ Irena Barisic, Chief Operating and Financial Officer
Stock symbol
ARDS
Transactions as of
Dec 8, 2022
Transactions value $
$0
Form type
3
Date filed
12/19/2022, 05:05 AM
Next filing
Mar 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARDS Common Stock, par value $0.0001 per share 5.17M Dec 8, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.